SEC Form D private-offering filing

Inflammasome Therapeutics, Inc.

Name: Inflammasome Therapeutics, Inc. - new SEC Form D private-offering filing, Newton, MA
Published: 2026-05-04

A new SEC Form D private-offering notice from Newton, MA, a $13,155,645 filer-stated offering target in Biotech. The source filing is one click away.

Inflammasome Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing oral and implant therapies that target inflammasome activation for retinal and neurodegenerative diseases like geographic atrophy, Alzheimer's, and Parkinson's.

Filed 2026-05-04Filed to raise $13,155,645First money in 2026-02-27Raised so far $13,155,645HQ (as filed) Newton, MASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified inflam.com↗Named in the filing 5 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.